Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ: BNTX )

114.42 +1.99 (+1.77%)
Streaming Delayed Price Updated: 11:44 AM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
65 66 Next >
FDA Authorizes Pfizer/BioNtech's Updated COVID-19 Booster Shots For Kids 5-11 Years
Via Benzinga
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
From BioNTech SE
Via GlobeNewswire
Moderna, BioNTech And Some Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mostly higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
From Pfizer Inc.
Via Business Wire
Pfizer's Partner BioNTech Signs Research Pact With Australia
Via Benzinga
Is Pfizer Stock Still Worth Buying After the Pandemic?
Pharmaceutical giant Pfizer (NYSE: PFE) is literally synonymous with COVID-19 vaccines, and as a result, Pfizer stock continues to beat expectations. 
Via MarketBeat
Exposures COVID-19
Dear NVAX Stock Fans, Mark Your Calendars for Oct. 11
Shares of NVAX stock are climbing ahead of the World Vaccine Congress Europe 2022, where Novavax will share new vaccine data. 
Via InvestorPlace
Pfizer's Executive Says European COVID-19 Vaccine Contract Negotiations Did Not Happen Over Text Message
A Pfizer Inc (NYSE: PFE) executive has "categorically" ruled out that the pharma giant's chief executive agreed on the European COVID-19 contract via mobile phone text messages. 
Via Benzinga
7 Blue-Chip Stocks That Are Too Cheap to Ignore
It's time to pounce on the opportunity to buy high-quality at bargain prices, with these seven cheap blue-chip stocks. 
Via InvestorPlace
Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine
Via Benzinga
3 Dirt-Cheap Stocks That Could Soar 48% to 68%, According to Wall Street
These stocks could attract both value and growth investors. 
Via The Motley Fool
BioNTech and Australia’s State of Victoria Form Strategic Partnership to Establish mRNA Research Center and Manufacturing Facility
From BioNTech SE
Via GlobeNewswire
Top Five Weekend Stock Stories - Sunday, Oct. 2nd
Catch up on the weekend's top five stories with this must read list. 
Via Talk Markets
As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster
Via Benzinga
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over. 
Via InvestorPlace
iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26
Bloomberg 
Via Benzinga
Pfizer/BioNTech Seek FDA Emergency Nod For Updated COVID-19 Shot For Kids Under 11 Years
Via Benzinga
Pfizer CEO Contracts COVID-19 Infection For Second Time
Pfizer Inc's (NYSE: PFE) CEO Albert Bourla said he had tested positive for COVID-19. 
Via Benzinga
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges
Last week, Moderna Inc (NASDAQ: MRNA) said it asked the FDA to authorize the use of its updated booster shot in children ages 6 to 17. The company expects to complete a request for the use of the... 
Via Benzinga
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age
From Pfizer Inc.
Via Business Wire
Switzerland To Dispose 10M Expired COVID-19 Vaccine Doses From Moderna
Via Benzinga
Why Is Novavax (NVAX) Stock Falling Today?
Novavax still has cash, but it needs to get approval for another vaccine if NVAX stock is to be worth buying again. 
Via InvestorPlace
Nikola, Super Micro Computer And Other Big Losers From Monday
U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Check Out What Whales Are Doing With BNTX
Someone with a lot of money to spend has taken a bullish stance on BioNTech (NASDAQ:BNTX). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?
Vaccine stocks are taking it on the chin following President Joe Biden's comments that the "pandemic is over." What now? 
Via InvestorPlace
Why BioNTech, Moderna And Novavax Shares Are Diving
BioNTech SE - ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA) and Novavax, Inc. (NASDAQ: NVAX) are all trading lower during Mo 
Via Benzinga
The Silver Lining For Pfizer, Moderna In This Month's IBD/TIPP Poll
The companies recently launched their updated Covid booster shots. 
Via Investor's Business Daily
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
Via Benzinga
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
From Pfizer Inc.
Via Business Wire
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
65 66 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.